Literature DB >> 18428345

Diagnosis of fanconi anemia by diepoxybutane analysis.

Arleen D Auerbach1.   

Abstract

Fanconi anemia (FA) is an autosomal recessive syndrome characterized by progressive pancytopenia and a high risk of malignancies, particularly acute myelogenous leukemia (AML). Diepoxybutane (DEB) analysis is the preferred test for FA because other agents have higher rates of false-positive and false-negative results. Basic Protocol in this unit applies the DEB test to rule out a diagnosis of FA using a peripheral blood sample from the patient. Support Protocol 1 provides instructions for working with DEB. Support Protocol 2 describes staining slides for chromosome-breakage analysis that is performed on unbanded metaphase preparations. Alternate Protocol 2 provides a detailed method for applying the DEB test to cultured fibroblasts that grow as a monolayer attached to the bottom of the flask. outlines methods for using the DEB test for prenatal diagnosis of FA, utilizing fetal cells obtained by chorionic villus sampling (CVS), amniocentesis, or fetal blood sampling. Fanconi anemia (FA) is an autosomal recessive syndrome characterized by progressive pancytopenia and a high risk of malignanci.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 18428345     DOI: 10.1002/0471142905.hg0807s37

Source DB:  PubMed          Journal:  Curr Protoc Hum Genet        ISSN: 1934-8258


  13 in total

1.  Prevalence of FA-D2 rare complementation group of Fanconi anemia in Serbia.

Authors:  Vujić Dragana; Petrović Sandra; Lazić Emilija; Kuzmanović Miloš; Leskovac Andreja; Joksić Ivana; Mićić Dragan; Jovanović Ankica; Zečević Zeljko; Guć-Šćekić Marija; Cirković Sanja; Joksić Gordana
Journal:  Indian J Pediatr       Date:  2013-12-10       Impact factor: 1.967

Review 2.  Susceptibility pathways in Fanconi's anemia and breast cancer.

Authors:  Alan D D'Andrea
Journal:  N Engl J Med       Date:  2010-05-20       Impact factor: 91.245

3.  Persistence and repair of bifunctional DNA adducts in tissues of laboratory animals exposed to 1,3-butadiene by inhalation.

Authors:  Melissa Goggin; Dewakar Sangaraju; Vernon E Walker; Jeffrey Wickliffe; James A Swenberg; Natalia Tretyakova
Journal:  Chem Res Toxicol       Date:  2011-04-13       Impact factor: 3.739

4.  Partial MCM4 deficiency in patients with growth retardation, adrenal insufficiency, and natural killer cell deficiency.

Authors:  Laure Gineau; Céline Cognet; Nihan Kara; Francis Peter Lach; Jean Dunne; Uma Veturi; Capucine Picard; Céline Trouillet; Céline Eidenschenk; Said Aoufouchi; Alexandre Alcaïs; Owen Smith; Frédéric Geissmann; Conleth Feighery; Laurent Abel; Agata Smogorzewska; Bruce Stillman; Eric Vivier; Jean-Laurent Casanova; Emmanuelle Jouanguy
Journal:  J Clin Invest       Date:  2012-02-22       Impact factor: 14.808

Review 5.  Fanconi anemia: current insights regarding epidemiology, cancer, and DNA repair.

Authors:  Jasmine D Peake; Eishi Noguchi
Journal:  Hum Genet       Date:  2022-05-21       Impact factor: 5.881

6.  Diagnosis of Fanconi anemia in patients with bone marrow failure.

Authors:  Fernando O Pinto; Thierry Leblanc; Delphine Chamousset; Gwenaelle Le Roux; Benoit Brethon; Bruno Cassinat; Jérôme Larghero; Jean-Pierre de Villartay; Dominique Stoppa-Lyonnet; André Baruchel; Gérard Socié; Eliane Gluckman; Jean Soulier
Journal:  Haematologica       Date:  2009-03-10       Impact factor: 9.941

Review 7.  Fanconi anemia.

Authors:  Allison M Green; Gary M Kupfer
Journal:  Hematol Oncol Clin North Am       Date:  2009-04       Impact factor: 3.722

8.  Recognizing familial myeloid leukemia in adults.

Authors:  Eric M Nickels; Jesse Soodalter; Jane E Churpek; Lucy A Godley
Journal:  Ther Adv Hematol       Date:  2013-08

9.  Bone Marrow Mesenchymal Stem Cells Carrying FANCD2 Mutation Differ from the Other Fanconi Anemia Complementation Groups in Terms of TGF-β1 Production.

Authors:  Ilgin Cagnan; Aysen Gunel-Ozcan; Fatima Aerts-Kaya; Najim Ameziane; Baris Kuskonmaz; Josephine Dorsman; Fatma Gumruk; Duygu Uckan
Journal:  Stem Cell Rev Rep       Date:  2018-06       Impact factor: 5.739

10.  Telomerase Dysfunction in the Tumorigenesis of Genetic Disorders.

Authors:  Maha Mohamed Farid Aql; Seham Abd-El Ghafour Bahget; Naglaa Kholoussi; Ghada Mohamed El Hossiny Abdel-Salam; Haiam Abdel Raouf; Maha Mohamed Eid; Rania El-Bialy Esmail
Journal:  Int J Mol Cell Med       Date:  2021-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.